Calcium channel blockers and losartan are associated with a lower risk of incident gout, while angiotensin-converting enzyme inhibitors, diuretics, β blockers, and non-losartan angiotensin II receptor blockers are associated with an increased risk of gout. This evidence concerns the gene ACE and gout.